Levy Raphi 4

What Happened
Levy Raphi, Chief Financial Officer of Alpha Tau Medical Ltd. (DRTS), sold 20,000 shares on 2026-06-30. The Form 4 reports the transaction as a sale (code S) at $12.00 per share with reported proceeds of $240,044. This is a sale (not a purchase), which is often routine insider selling rather than a direct bullish signal.

Key Details

• Transaction date and price: 2026-06-30 — 20,000 shares at $12.00 per share; reported proceeds $240,044.
• Transaction type: Sale (Form 4 code S); described in filing as "open market or private sale."
• Filing date / timeliness: Form 4 filed 2026-07-01 (one day after the trade); appears to be filed within the usual two-business-day window.
• Shares owned after transaction: Not specified in the provided filing details.
• Footnotes/plan statements: No 10b5-1 plan, tax-withholding, or other footnotes were indicated in the provided summary.

Context
Sales by executives can be for many reasons (diversification, personal liquidity, tax planning) and do not necessarily indicate negative views about the company. For retail investors, purchases are typically weighted more heavily as a positive signal; this filing documents a routine insider sale.